Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta‐analysis of randomized controlled trials

  title={Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta‐analysis of randomized controlled trials},
  author={Jing Gong and Xin Qin and Fen Yuan and Meilin Hu and Guang Chen and Ke Fang and Ding-kun Wang and Shu-jun Jiang and Jingbin Li and Yan Zhao and Zhaoyi Huang and Hui Dong and Fu-er Lu},
  journal={Molecular Nutrition \& Food Research},
SCOPE This study aimed to systematically investigate whether sugarcane policosanol was effective and safe on dyslipidemia. METHODS AND RESULTS A total of 11 databases including the PubMed, Web of science, Embase, Scopus, the Cochrane library and SinoMed databases were searched for available studies investigating the effects of policosanol on dyslipidemia. A total of 22 studies including 1886 subjects were included in the analysis. The pooled results showed that compared with placebo… 

Figures and Tables from this paper

Short-Term Consumption of Cuban Policosanol Lowers Aortic and Peripheral Blood Pressure and Ameliorates Serum Lipid Parameters in Healthy Korean Participants: Randomized, Double-Blinded, and Placebo-Controlled Study
12-week consumption of policosanol resulted in significant reductions of peripheral blood pressure (BP), aortic SBP and DBP, mean arterial pressure (MAP), and serum TC and LDL-C with elevation of % HDL-C.
Policosanols: Chemistry, Occurrence, and Health Effects
Purpose of ReviewOverwhelming evidence indicates that reduction of blood low-density lipoprotein cholesterol (LDL-C), ratio of LDL-C/HDL-C, and TG/HDL-C ameliorate the occurrence of atherosclerotic
Long-Term Consumption of Cuban Policosanol Lowers Central and Brachial Blood Pressure and Improves Lipid Profile With Enhancement of Lipoprotein Properties in Healthy Korean Participants
The study results suggest that long-term policosanol consumption simultaneously reduces peripheral BP as well as aortic BP accompanied by elevation of LDL-C and % HDL-C in TC in a dose-dependent manner.
Enhancement of HDL by Policosanol
  • Kyung-Hyun Cho
  • Medicine
    High-Density Lipoproteins as Biomarkers and Therapeutic Tools
  • 2019
It is well established that a higher level of serum HDL-cholesterol is associated with lower incidence of coronary artery disease and increased longevity and it has been reported that consumption of PCO can significantly reduce serum total cholesterol and LDL-ch cholesterol levels as well as raise serum cholesterol levels.
Therapeutic potential of policosanol in the concurrent management of dyslipidemia and non-alcoholic fatty liver disease
Treatment with policosanol markedly reduced the elevated SGOT, SGPT, and ALP levels in HFD-fed rats and significantly reduced hepatic oxidative stress manifest by reduced malondialdehyde (MDA) and increased glutathione (GSH) level.
Blood Pressure Lowering Effect of Cuban Policosanol is Accompanied by Improvement of Hepatic Inflammation, Lipoprotein Profile, and HDL Quality in Spontaneously Hypertensive Rats
Eight weeks of policosanol consumption in SHR resulted in remarkable reduction of blood pressure, serum aldosterone, and serum TG levels along with the elevation of HDL-C and improvement of hepatic inflammation.
Supplementation with Octacosanol Affects the Level of PCSK9 and Restore Its Physiologic Relation with LDL-C in Patients on Chronic Statin Therapy
This study shows that DS can restore statin disrupted physiologic positive correlation between PCSK9 and LDL-C, and controlling its rise by statins may be important in prevention of cardiovascular events.
Policosanol: Extraction and biological functions


Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial.
Policosanol does not alter the serum lipid profile over an 8-wk period in adults with mild hypercholesterolemia and is well tolerated, and no significant adverse events were noted.
Efficacy and safety of policosanol and pravastatin in treatment of hyperlipidemia in Chinese patients
The policosanol is superior to pravastatin in ADR and can significantly decrease TC,LDL-C,TC-HDl-C/HDL- C,Apo B_(100,Lpa) and Lpa.
Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
In patients with hypercholesterolemia or combined hyperlipidemia, the sugar cane-derived policosanol in usual and high doses does not demonstrate a reduction in lipid levels beyond placebo.
Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia
Sugar cane policosanol at doses of 20 mg daily showed no lipid lowering effects in subjects with primary hypercholesterolemia and body mass index, total cholesterol, HDL‐cholesterol, LDL‐ch cholesterol and triglyceride plasma levels did not change significantly in either group.
Comparison of the Efficacy, Safety and Tolerability of Policosanol versus Fluvastatin in Elderly Hypercholesterolaemic Women
The cholesterol-lowering effects of policosanol 10mg/day administered for 8 weeks to older women with type II hypercholesterolaemia were slightly better than those of fluvastatin 20 mg/day with respect to the extent of the changes in LDL-C, atherogenic indices and HDL-C levels.
Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.
Policosanol seems to be a very promising phytochemical alternative to classic lipid-lowering agents such as the statins and deserves further evaluation.